» Articles » PMID: 30709029

Medication Event Monitoring System for Infectious Tuberculosis Treatment in Morocco: A Retrospective Cohort Study

Overview
Publisher MDPI
Date 2019 Feb 3
PMID 30709029
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Non-adherence to tuberculosis (TB) treatment is a barrier to effective TB control. We investigated the effectiveness of a Medication Event Monitoring System (MEMS) as a tailored adherence-promoting intervention in Morocco. We compared patients who received a MEMS (n = 206) with patients who received standard TB care (n = 141) among new active TB patients with sputum smear-positive. The mean total medication days were 141.87 ± 29.5 in the control group and 140.85 ± 17.9 in the MEMS group ( = 0.7147), and the mean age and sex were not different between the two groups ( > 0.05). The treatment success rate was significantly higher in the MEMS group than in the control group (odds ratio (OR): 4.33, 95% confidence interval (CI): 2.13⁻8.81, < 0.001), and the lost to follow-up rate was significantly lower in the MEMS group than in the control group (OR: 0.03, 95% CI: 0.05⁻0.24, < 0.001) after adjusting for sex, age, and health centers. The mean drug adherence rate in the first month was significantly higher in the MEMS group than in the control group ( = 0.023). MEMS increased TB treatment success rate and decreased the lost to follow-up rate overall for infectious TB patients in a Moroccan rural area.

Citing Articles

Implementation outcomes of tuberculosis digital adherence technologies: a scoping review using the RE-AIM framework.

Chilala C, Foster N, Bahukudumbi S, Mohamed M, Zary M, Kafie C BMJ Glob Health. 2025; 10(2).

PMID: 39947715 PMC: 11831268. DOI: 10.1136/bmjgh-2024-016535.


Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review.

Kafie C, Mohamed M, Zary M, Chilala C, Bahukudumbi S, Gore G BMJ Glob Health. 2024; 9(10).

PMID: 39477335 PMC: 11529515. DOI: 10.1136/bmjgh-2024-015654.


Distribution of mHealth applications in Germany: analysis of the FeverApp registry.

Gwiasda M, Rathjens L, Martin D, Mohler R, Schwarz S, Jenetzky E J Int Med Res. 2024; 52(9):3000605241274550.

PMID: 39253830 PMC: 11388306. DOI: 10.1177/03000605241274550.


Perception, acceptability and challenges of digital adherence technology among TB healthcare workers.

Gordon I, Odume B, Ogbudebe C, Chukwuogo O, Nwokoye N, Useni S Public Health Action. 2024; 14(2):61-65.

PMID: 38957501 PMC: 11216288. DOI: 10.5588/pha.24.0008.


Current State and Prospects of Telemedicine in Morocco: Analysis of Challenges, Initiatives, and Regulatory Framework.

Jallal M, Serhier Z, Berrami H, Bennani Othmani M Cureus. 2024; 15(12):e50963.

PMID: 38259391 PMC: 10801268. DOI: 10.7759/cureus.50963.


References
1.
Kolifarhood G, Khorasani-Zavareh D, Salarilak S, Shoghli A, Khosravi N . Spatial and non-spatial determinants of successful tuberculosis treatment outcomes: An implication of Geographical Information Systems in health policy-making in a developing country. J Epidemiol Glob Health. 2015; 5(3):221-30. PMC: 7320527. DOI: 10.1016/j.jegh.2014.11.001. View

2.
Mundra A, Deshmukh P, Dawale A . Magnitude and determinants of adverse treatment outcomes among tuberculosis patients registered under Revised National Tuberculosis Control Program in a Tuberculosis Unit, Wardha, Central India: A record-based cohort study. J Epidemiol Glob Health. 2017; 7(2):111-118. PMC: 7320429. DOI: 10.1016/j.jegh.2017.02.002. View

3.
Broomhead S, Mars M . Retrospective return on investment analysis of an electronic treatment adherence device piloted in the Northern Cape Province. Telemed J E Health. 2011; 18(1):24-31. DOI: 10.1089/tmj.2011.0143. View

4.
McCambridge J, Witton J, Elbourne D . Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2013; 67(3):267-77. PMC: 3969247. DOI: 10.1016/j.jclinepi.2013.08.015. View

5.
Sinkou H, Hurevich H, Rusovich V, Zhylevich L, Falzon D, de Colombani P . Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience. Eur Respir J. 2017; 49(3). PMC: 5380873. DOI: 10.1183/13993003.02049-2016. View